Jan Moller Mikkelsen

Track

Insider profile

Jan Moller Mikkelsen's trades of Ascendis Pharma A/S's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-05 2026-03-05
PrS Proposed sale
88,795
163.62
US$4,205,491 		88,795 163.62 US$4,205,491
2026-01-13 2026-01-13
PrS Proposed sale
94,282
79.66
US$4,668,869 		94,282 79.66 US$4,668,869
2025-12-02 2025-12-02
PrS Proposed sale
95,768
394.75
US$2,103,103 		95,768 394.75 US$2,103,103
2025-08-20 2025-08-20
PrS Proposed sale
3,000
192.80
US$578,385 		3,000 192.80 US$578,385
2025-03-05 2025-03-05
PrS Proposed sale
7,789
155.13
US$1,208,292 		7,789 155.13 US$1,208,292
2025-03-03 2025-03-03
PrS Proposed sale
7,800
155.14
US$1,210,089 		7,800 155.14 US$1,210,089
2024-12-10 2024-12-10
PrS Proposed sale
5,292
129.13
US$683,342 		5,292 129.13 US$683,342
2024-03-05 2024-03-01
PrS Proposed sale
15,774
147.76
US$2,330,766 		15,774 147.76 US$2,330,766
2024-02-28 2024-02-28
PrS Proposed sale
200,000
146.93
US$29,386,000 		200,000 146.93 US$29,386,000
2024-02-09 2024-02-09
PrS Proposed sale
5,483
140.40
US$769,788 		5,483 140.40 US$769,788
2023-11-30 2023-11-30
PrS Proposed sale
24,000
97.87
US$2,348,880 		24,000 97.87 US$2,348,880
2023-09-11 2023-09-08
PrS Proposed sale
66,755
97.58
US$6,513,952 		66,755 97.58 US$6,513,952
2023-09-08 2023-09-08
PrS Proposed sale
66,755
97.58
US$6,513,952 		66,755 97.58 US$6,513,952
2023-05-10 2023-05-10
PrS Proposed sale
4,952
98.05
US$485,546 		4,952 98.05 US$485,546